Marinus Pharmaceuticals I... (MRNS)
NASDAQ: MRNS
· Real-Time Price · USD
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -1.04 | -0.51 | -0.82 | -0.92 | -0.82 | -1.12 | -0.65 | -0.33 | 0.22 | -0.29 | -1.03 | -0.96 | -1.34 | -1.73 | -1.3 |
PEG Ratio | 0.03 | 0.07 | 0.10 | -0.04 | n/a | 0.12 | 0.05 | 0.00 | -0.00 | -0.00 | 0.04 | -0.02 | 0.07 | 0.14 | -0.04 |
PS Ratio | 11.79 | 9.07 | 16.58 | 21.45 | 14.77 | 23.51 | 8.63 | 6.25 | 26.39 | 25.12 | 6.09 | 71.78 | 10.35 | 86.38 | 78.43 |
PB Ratio | -1.51 | -1.54 | -7.75 | 9.20 | 1.99 | 2.49 | 1.05 | 0.39 | 0.75 | 9.36 | 2.14 | 2.04 | 1.33 | 1.73 | 1.23 |
P/FCF Ratio | -4.9 | -2.37 | -3.4 | -5.71 | -4.29 | -5.87 | -2.16 | -2.03 | -2 | -1.32 | -3.11 | -4.86 | 23.11 | -6.91 | -8.53 |
P/OCF Ratio | -5.18 | -2.37 | -3.4 | -5.71 | -4.31 | -5.87 | -2.16 | -2.04 | -2.08 | -1.34 | -3.12 | -5.02 | 19.38 | -7.17 | -8.76 |
OCF/S Ratio | -2.28 | -3.83 | -4.88 | -3.75 | -3.43 | -4.01 | -4 | -3.06 | -12.67 | -18.81 | -1.95 | -14.31 | 0.53 | -12.05 | -8.96 |
Debt / Equity Ratio | -0.84 | -2.03 | -6.85 | 6.58 | 1.36 | 1.84 | 1.20 | 0.63 | 0.89 | 15.12 | 1.79 | 0.76 | 0.52 | 0.12 | 0.03 |
Quick Ratio | 1.47 | 2.15 | 2.93 | 4.01 | 6.29 | 7.50 | 9.26 | 4.38 | 8.40 | 4.37 | 6.91 | 3.04 | 4.07 | 7.24 | 8.05 |
Current Ratio | 1.66 | 2.28 | 3.07 | 4.07 | 6.38 | 7.60 | 9.26 | 4.38 | 8.41 | 4.37 | 6.91 | 3.03 | 4.07 | 7.24 | 8.05 |
Asset Turnover | 0.13 | 0.09 | 0.06 | 0.04 | 0.04 | 0.03 | 0.05 | 0.03 | 0.01 | 0.02 | 0.10 | 0.01 | 0.06 | 0.02 | 0.01 |
Interest Coverage | -5.49 | -6.98 | -8.24 | -8.24 | -7.46 | -7.47 | -7.95 | -7.92 | -11.43 | -13.84 | -10.57 | -17.46 | -28.27 | -66.91 | n/a |
Return on Equity | 0.36 | 0.76 | 2.35 | -2.49 | -0.6 | -0.56 | -0.41 | -0.3 | 0.87 | -8.21 | -0.52 | -0.53 | -0.25 | -0.25 | -0.24 |
Return on Assets | -0.38 | -0.41 | -0.28 | -0.24 | -0.16 | -0.16 | -0.15 | -0.13 | 0.39 | -0.36 | -0.15 | -0.21 | -0.12 | -0.19 | -0.2 |
Return on Invested Capital | -0.49 | -0.51 | -0.32 | -0.24 | -0.18 | -0.17 | -0.16 | -0.15 | -0.18 | -0.42 | -0.16 | -0.28 | -0.16 | -0.22 | -0.23 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.92 | 0.89 | 0.88 | 0.86 | 0.94 | 0.94 | 0.98 | 0.96 | 0.98 | -11.01 | 0.92 | -10.85 | 0.85 | -8.74 | -9.29 |
Net Profit Margin | -2.84 | -4.45 | -5.04 | -5.81 | -4.49 | -5.25 | -3.33 | -4.79 | 30.61 | -22.03 | -1.48 | -18.62 | -1.93 | -12.51 | -15.03 |
Pretax Profit Margin | -2.84 | -4.45 | -5.04 | -5.81 | -4.49 | -5.5 | -3.35 | -4.56 | 32.07 | -22.03 | -1.36 | -18.62 | -1.93 | -12.51 | -15.03 |
Operating Profit Margin | -2.47 | -4 | -4.66 | -4.93 | -4.31 | -5.17 | -3.18 | -4.08 | -12.86 | -20.54 | -1.26 | -17.84 | -1.9 | -12.33 | -15.04 |
FCF Margin | -2.41 | -3.83 | -4.88 | -3.76 | -3.44 | -4.01 | -4 | -3.07 | -13.21 | -19 | -1.96 | -14.78 | 0.45 | -12.5 | -9.2 |
EBITDA Margin | -2.47 | -3.86 | -4.45 | -5.19 | -3.89 | -4.78 | -2.93 | -4.03 | -12.8 | -20.49 | -1.23 | -17.49 | -1.84 | -12.28 | -14.98 |